Mesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study.

Dauletova M, Hafsan H, Mahhengam N, Zekiy AO, Ahmadi M, Siahmansouri H

Open source

DOI
10.1016/j.clim.2021.108712
Published
2021 May
Container
Clinical immunology (Orlando, Fla.)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.clim.2021.108712,
  title = {Mesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study.},
  author = {Dauletova M and Hafsan H and Mahhengam N and Zekiy AO and Ahmadi M and Siahmansouri H},
  year = {2021},
  journal = {Clinical immunology (Orlando, Fla.)},
  doi = {10.1016/j.clim.2021.108712},
  url = {https://doi.org/10.1016/j.clim.2021.108712}
}

RIS

TY  - JOUR
TI  - Mesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study.
AU  - Dauletova M
AU  - Hafsan H
AU  - Mahhengam N
AU  - Zekiy AO
AU  - Ahmadi M
AU  - Siahmansouri H
PY  - 2021
JO  - Clinical immunology (Orlando, Fla.)
DO  - 10.1016/j.clim.2021.108712
UR  - https://doi.org/10.1016/j.clim.2021.108712
ER  - 

APA

M, D., H, H., N, M., AO, Z., M, A., & H, S. (2021). Mesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study.. Clinical immunology (Orlando, Fla.). https://doi.org/10.1016/j.clim.2021.108712

Source records